BioAtla, Inc.
BCAB
$0.356
-$0.0002-0.06%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -42.37% | -58.80% | -53.67% | -42.60% | -24.67% |
| Gross Profit | 57.85% | 69.70% | 64.27% | 53.28% | 24.67% |
| SG&A Expenses | -13.29% | -11.62% | -15.83% | -13.68% | -9.96% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -32.01% | -37.63% | -34.50% | -25.04% | -9.01% |
| Operating Income | 42.01% | 46.41% | 42.98% | 33.52% | 9.01% |
| Income Before Tax | 43.08% | 48.11% | 43.48% | 34.06% | 10.28% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 43.08% | 48.11% | 43.48% | 34.06% | 10.28% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 43.08% | 48.11% | 43.48% | 34.06% | 10.28% |
| EBIT | 42.01% | 46.41% | 42.98% | 33.52% | 9.01% |
| EBITDA | 42.12% | 46.61% | 43.16% | 33.75% | 9.03% |
| EPS Basic | 49.41% | 51.05% | 44.32% | 36.01% | 17.74% |
| Normalized Basic EPS | 49.42% | 51.05% | 44.32% | 36.00% | 17.74% |
| EPS Diluted | 49.41% | 51.05% | 44.32% | 36.01% | 17.74% |
| Normalized Diluted EPS | 49.42% | 51.05% | 44.32% | 36.00% | 17.74% |
| Average Basic Shares Outstanding | 11.77% | 6.70% | 1.67% | 3.25% | 9.01% |
| Average Diluted Shares Outstanding | 11.77% | 6.70% | 1.67% | 3.25% | 9.01% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |